At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 30 enrolled
Drug / intervention
Ginger Root Extract (Pure Encapsulations) +1 moredrug
Likely dose
Ginger Root Extract (Pure Encapsulations) 2.0 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer
In Brief
A Phase 2 clinical trial evaluating Ginger Root Extract (Pure Encapsulations) and Placebo Capsule for Colorectal Cancer. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if ginger root extract when taken daily for 28 days is able to decrease levels of inflammatory chemicals called eicosanoids in the gut tissue of people who are at normal risk and those at increased of developing colorectal cancer compared to people taking placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedApr 2011
Primary CompletionMay 2011
Study CompletionDec 2012
TodayJul 2026
First PostedApr 29, 2011
Enrollment StartApr 1, 2007
Primary CompletionMay 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 15.2 years ago
Interventions
Ginger Root Extract (Pure Encapsulations)drug
2.0 g per day (10:1 extract)
Placebo Capsuledietary
2.0 g per day